Challenges and Initiatives in Diversity, Equity and Inclusion in Cancer Molecular Imaging

A diverse biomedical workforce is essential to achieve excellence in patient care, clinical translational, and basic research. Diversity, equity, and inclusion challenges in cancer molecular represent a combination of the challenges facing the science, technology, engineering, and mathematics (STEM)...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 11; p. 638692
Main Authors Daldrup-Link, Heike E., Esposito, Giuseppe, Bhujwalla, Zaver M.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 09.04.2021
Subjects
Online AccessGet full text
ISSN2234-943X
2234-943X
DOI10.3389/fonc.2021.638692

Cover

More Information
Summary:A diverse biomedical workforce is essential to achieve excellence in patient care, clinical translational, and basic research. Diversity, equity, and inclusion challenges in cancer molecular represent a combination of the challenges facing the science, technology, engineering, and mathematics (STEM) field, and challenges in Radiology and Nuclear Medicine. Although there is a growing awareness of conscious and unconscious bias that negatively affect the cancer imaging world, many challenges remain such as overcoming barriers to entry into the pipeline, avoiding program dropout, and providing long-term career prospect. The COVID-19 pandemic has resulted in a significant setback and further highlighted problems faced by women and underrepresented minorities. In this perspective, we have identified some of the challenges faced and highlighted ongoing and future initiatives to address these challenges.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Cancer Imaging and Image-directed Interventions, a section of the journal Frontiers in Oncology
Edited by: Tone Frost Bathen, Norwegian University of Science and Technology, Norway
Reviewed by: Jannie Wijnen, University Medical Center Utrecht, Netherlands; Egidio Iorio, National Institute of Health (ISS), Italy
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.638692